{"id":"W6908434345","doi":"10.25934/pr00006175.0","title":"Available IPD datapackage for study 'A Bioequivalence Study of the Fixed Dose Combination Dapagliflozin/Metformin Tablet (5 mg/850 mg) Relative to a 5 mg Dapagliflozin Tablet and an 850 mg Metformin (Glucophage® Marketed in Canada by Sanofi-Aventis) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States'","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Metformin; Dapagliflozin; Fixed-dose combination; Glimepiride; Pharmacokinetics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002917022,0.002484341,0.002138254,0.002246837,0.000602798,0.001918293,0.003252646,0.003547498,0.07834838],"category_scores_gemma":[0.01328602,0.0007868148,0.002383066,0.00414658,0.000518771,0.001034074,0.001599799,0.001829239,0.06304619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00150806,"about_ca_system_score_gemma":0.003298068,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02189339,"about_ca_topic_score_gemma":0.03436789,"domain_scores_codex":[0.9981942,0.0004616449,0.0002875123,0.0004536746,0.0004246657,0.000178392],"domain_scores_gemma":[0.9949368,0.002164539,0.0008109559,0.0009330655,0.0008673391,0.0002873097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005345712,0.00008362721,0.001788503,0.003095754,0.0002537676,0.00003879269,0.00002237503,0.001008302,0.0002095712,0.0005372728,0.9882917,0.004135755],"study_design_scores_gemma":[0.004120582,0.0001817359,0.00886397,0.001178153,0.0004164175,0.0001262406,0.00004833226,0.001858869,0.0006208972,0.002300447,0.9802085,0.00007573422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.0001282253,0.0001206354,0.00007218468,0.00005480053,0.00001753522,0.00002268234,0.9991315,0.0001445891,0.0003078718],"genre_scores_gemma":[0.0006117472,0.0000860123,0.0003170059,0.00008161325,0.00000901779,0.0001703716,0.9982192,0.00004647349,0.0004584996],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.9781066,"threshold_uncertainty_score":0.2621014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02844765649905483,"score_gpt":0.322918681402331,"score_spread":0.2944710249032762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}